Voleon Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Voleon Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,174	Closed	-$960K	–	805
2026 Q1	$960K	Sell	24,174 -54,900	-69%	-$1.4M	0.02%	449
2025 Q4	$1.98M	Buy	+79,074	New	+$2M	0.04%	339

Voleon Capital Management's CNTA Position: Q2 2026 in Review

Voleon Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 24,174 shares — an estimated $960K sold.

Voleon Capital Management first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $1.98M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Voleon Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Voleon Capital Management sold 24,174 Centessa Pharmaceuticals shares in Q2 2026, an estimated $960K.
Voleon Capital Management first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Voleon Capital Management's Centessa Pharmaceuticals position peaked at $1.98M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.